«Population pharmacokinetic analysis of blood and joint fluid concentrations
of robenacoxib from healthy dogs and dogs with osteoarthritis.»
To evaluate the toxicity and systemic exposure
of robenacoxib tablets when administered to healthy adult dogs that received test article at 0.5, 1.5, and 2.5 times the maximum target exposure based on the inherent dose bands of the tablet sizes.
A randomized, blinded, placebo - controlled pivotal field study to evaluate the effectiveness and safety
of robenacoxib (tablets) when administered at a dose of 2 mg / kg once daily for 3 days for the control of postoperative pain and inflammation associated with soft - tissue surgery in dogs.
Not exact matches
Subcutaneous administration
of Onsior (
robenacoxib) injection at a dose
of 2 mg / kg (0.91 mg / lb) once daily for up to 3 days, with the first dose administered approximately 45 minutes prior to surgery, was effective and well - tolerated for the control
of postoperative pain and inflammation with soft - tissue surgery in dogs.
Onsior ® (
robenacoxib) injection is indicated for the control
of postoperative pain and inflammation associated with orthopedic surgery, ovariohysterectomy and castration in cats ≥ 4 months
of age; for up to a maximum
of 3 days.